Entry - #614882 - PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A - OMIM
# 614882

PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A


Other entities represented in this entry:

PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 12, INCLUDED; CG12, INCLUDED
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP G, INCLUDED; CGG, INCLUDED

Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
6q24.2 Peroxisome biogenesis disorder 10A (Zellweger) 614882 AR 3 PEX3 603164
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
HEAD & NECK
Face
- Prominent midface
- Micrognathia
Ears
- Abnormal ears
Eyes
- Hypertelorism
- Prominent epicanthic folds
- Downslanting palpebral fissures
- Corneal haze without cataract
Nose
- Prominent nose
Mouth
- High-arched palate
CARDIOVASCULAR
Heart
- Multiple congenital heart defects
CHEST
Ribs Sternum Clavicles & Scapulae
- Irregular costochondral ossification
ABDOMEN
Liver
- Enlarged liver
- No peroxisomes
SKELETAL
Skull
- Widely patent metopic and sagittal sutures
MUSCLE, SOFT TISSUES
- Hypotonia
NEUROLOGIC
Central Nervous System
- Focal microgyria
- Seizures, controlled by medication
- Abnormalities of inferior olivary nucleus
Peripheral Nervous System
- Absent deep tendon reflexes
PRENATAL MANIFESTATIONS
Movement
- Decreased fetal movement
LABORATORY ABNORMALITIES
- Elevated very long chain fatty acids
- Decreased pristanic acid beta-oxidation
- Decreased alkyl DHAP synthase
- Decreased DHAP-AT
- No peroxisomes
MISCELLANEOUS
- Peroxisome biogenesis disorder complementation group 12, CG12
- Peroxisome biogenesis disorder complementation group G, CGG
- Clinical details based on report of 2 patients (last curated February 2017)
MOLECULAR BASIS
- Caused by mutation in the peroxisome biogenesis factor 3 gene (PEX3, 603164.0001)
Peroxisome biogenesis disorder - PS214100 - 27 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32 Peroxisome biogenesis disorder 6B AR 3 614871 PEX10 602859
1p36.32 Peroxisome biogenesis disorder 6A (Zellweger) AR 3 614870 PEX10 602859
1p36.22 Peroxisome biogenesis disorder 13A (Zellweger) AR 3 614887 PEX14 601791
1q21.1 Peroxisome biogenesis disorder 14B AR 3 614920 PEX11B 603867
1q23.2 Peroxisome biogenesis disorder 12A (Zellweger) AR 3 614886 PEX19 600279
2p15 Peroxisome biogenesis disorder 11A (Zellweger) AR 3 614883 PEX13 601789
2p15 Peroxisome biogenesis disorder 11B AR 3 614885 PEX13 601789
6p21.1 Peroxisome biogenesis disorder 4B AD, AR 3 614863 PEX6 601498
6p21.1 Peroxisome biogenesis disorder 4A (Zellweger) AR 3 614862 PEX6 601498
6p21.1 Heimler syndrome 2 AR 3 616617 PEX6 601498
6q23.3 Peroxisome biogenesis disorder 9B AR 3 614879 PEX7 601757
6q23.3 Rhizomelic chondrodysplasia punctata, type 1 AR 3 215100 PEX7 601757
6q24.2 Peroxisome biogenesis disorder 10A (Zellweger) AR 3 614882 PEX3 603164
6q24.2 ?Peroxisome biogenesis disorder 10B AR 3 617370 PEX3 603164
7q21.2 Peroxisome biogenesis disorder 1B (NALD/IRD) AR 3 601539 PEX1 602136
7q21.2 Peroxisome biogenesis disorder 1A (Zellweger) AR 3 214100 PEX1 602136
7q21.2 Heimler syndrome 1 AR 3 234580 PEX1 602136
8q21.13 Peroxisome biogenesis disorder 5B AR 3 614867 PEX2 170993
8q21.13 Peroxisome biogenesis disorder 5A (Zellweger) AR 3 614866 PEX2 170993
11p11.2 Peroxisome biogenesis disorder 8B AR 3 614877 PEX16 603360
11p11.2 Peroxisome biogenesis disorder 8A (Zellweger) AR 3 614876 PEX16 603360
12p13.31 Peroxisome biogenesis disorder 2A (Zellweger) AR 3 214110 PEX5 600414
12p13.31 Peroxisome biogenesis disorder 2B AR 3 202370 PEX5 600414
17q12 Peroxisome biogenesis disorder 3B AR 3 266510 PEX12 601758
17q12 Peroxisome biogenesis disorder 3A (Zellweger) AR 3 614859 PEX12 601758
22q11.21 Peroxisome biogenesis disorder 7B AR 3 614873 PEX26 608666
22q11.21 Peroxisome biogenesis disorder 7A (Zellweger) AR 3 614872 PEX26 608666

TEXT

A number sign (#) is used with this entry because this form of Zellweger syndrome (PBD10A) is caused by homozygous mutation in the PEX3 gene (603164) on chromosome 6q24.


Description

Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).

For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.

Individuals with PBDs of complementation group 12 (CG12, equivalent to CGG) have mutations in the PEX3 gene. For information on the history of PBD complementation groups, see 214100.


Clinical Features

Poulos et al. (1995) described 2 patients who formed a novel peroxisome biogenesis disorder complementation group (group G). Patient 1 was a male infant born to consanguineous Dutch parents. Decreased fetal movement had been noted and the infant was hypotonic at birth. Dysmorphic features included hypertelorism, prominent epicanthic folds, mild micrognathia, and high-arched palate. Ears were box-shaped and slightly low-set. The metopic and sagittal sutures were widely patent; anterior and posterior fontanels were in continuity. Seizures developed on day 1 of life and were controlled with treatment. The condition of the patient deteriorated and he died at 4 months of age. Autopsy showed irregular costochondral ossification in ribs and vertebrae, and marked hypercellularity of marrow preferentially affecting the myeloid series. The cerebrum showed focal microgyria with prominent subcortical ectopic neurons. The inferior olivary nucleus of the medulla was broken into islands with a marked concentration of neurons around the periphery of the nuclei. Patient 2 was the son of consanguineous Italian parents. Fetal movements were poor and the infant was cyanotic at birth, markedly hypotonic, and lacked deep tendon reflexes. He had a prominent midface and downslanting palpebral fissures, hypertelorism, small low-set ears, prominent nose, and high-arched palate. His facies were not considered typical of Zellweger syndrome. There was a slight corneal haze but no cataracts. The liver was enlarged. Echocardiography revealed a right-sided aortic arch, anomalous origin of the right pulmonary artery from the aorta, supravalvular pulmonary stenosis, secundum atrial septal defect, and membranous ventricular septal defect. Seizures developed in the first 20 hours and were controlled by phenobarbital. The infant died at 19 days of age of congestive heart failure. Autopsy showed mild focal microgyria but no obvious subcortical ectopic neurons. Inferior olives were in the form of a broad band, with no obvious concentration of neurons around the periphery. A similarly affected elder sib had died at 15 days of age. Both patients 1 and 2 lacked peroxisomes. Lab values were all abnormal and fell in ranges observed for patients with peroxisome biogenesis disorders.

Muntau et al. (2000) reported 2 unrelated patients with Zellweger syndrome of complementation group G. The patients were male infants from unrelated consanguineous Dutch and Italian families. One showed marked muscular hypotonia at birth. Dysmorphic features included hypertelorism, prominent epicanthic folds, and a high, broad forehead with round face. Seizures developed on day 1 but were controlled with treatment. His condition deteriorated rapidly, with death at age 4 months. The other patient was cyanotic and markedly hypotonic at birth with absent deep tendon reflexes. He had a prominent midface and an antimongoloid slant of the palpebral fissures, ocular hypertelorism, small low-set ears, a prominent nose, and a high-arched palate. The patient died at age 19 days. A brother had been similarly affected and died at age 15 days.


Molecular Genetics

In 2 unrelated patients with Zellweger syndrome of complementation group G, Muntau et al. (2000) identified 2 different homozygous mutations in the PEX3 gene (603164.0001, 603164.0002).


REFERENCES

  1. Muntau, A. C., Mayerhofer, P. U., Paton, B. C., Kammerer, S., Roscher, A. A. Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G. Am. J. Hum. Genet. 67: 967-975, 2000. [PubMed: 10958759, images, related citations] [Full Text]

  2. Poulos, A., Christodoulou, J., Chow, C. W., Goldblatt, J., Paton, B. C., Orii, T., Suzuki, Y., Shimozawa, N. Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J. Pediat. 127: 596-599, 1995. [PubMed: 7562283, related citations] [Full Text]

  3. Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., Moser, H. W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763: 1733-1748, 2006. [PubMed: 17055079, related citations] [Full Text]


Contributors:
Anne M. Stumpf - updated : 02/14/2017
Creation Date:
Anne M. Stumpf : 10/17/2012
carol : 03/02/2017
alopez : 02/14/2017
alopez : 10/25/2012
carol : 10/25/2012
alopez : 10/24/2012

# 614882

PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A


Other entities represented in this entry:

PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 12, INCLUDED; CG12, INCLUDED
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP G, INCLUDED; CGG, INCLUDED

ORPHA: 79189, 912;   DO: 0080484;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
6q24.2 Peroxisome biogenesis disorder 10A (Zellweger) 614882 Autosomal recessive 3 PEX3 603164

TEXT

A number sign (#) is used with this entry because this form of Zellweger syndrome (PBD10A) is caused by homozygous mutation in the PEX3 gene (603164) on chromosome 6q24.


Description

Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).

For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.

Individuals with PBDs of complementation group 12 (CG12, equivalent to CGG) have mutations in the PEX3 gene. For information on the history of PBD complementation groups, see 214100.


Clinical Features

Poulos et al. (1995) described 2 patients who formed a novel peroxisome biogenesis disorder complementation group (group G). Patient 1 was a male infant born to consanguineous Dutch parents. Decreased fetal movement had been noted and the infant was hypotonic at birth. Dysmorphic features included hypertelorism, prominent epicanthic folds, mild micrognathia, and high-arched palate. Ears were box-shaped and slightly low-set. The metopic and sagittal sutures were widely patent; anterior and posterior fontanels were in continuity. Seizures developed on day 1 of life and were controlled with treatment. The condition of the patient deteriorated and he died at 4 months of age. Autopsy showed irregular costochondral ossification in ribs and vertebrae, and marked hypercellularity of marrow preferentially affecting the myeloid series. The cerebrum showed focal microgyria with prominent subcortical ectopic neurons. The inferior olivary nucleus of the medulla was broken into islands with a marked concentration of neurons around the periphery of the nuclei. Patient 2 was the son of consanguineous Italian parents. Fetal movements were poor and the infant was cyanotic at birth, markedly hypotonic, and lacked deep tendon reflexes. He had a prominent midface and downslanting palpebral fissures, hypertelorism, small low-set ears, prominent nose, and high-arched palate. His facies were not considered typical of Zellweger syndrome. There was a slight corneal haze but no cataracts. The liver was enlarged. Echocardiography revealed a right-sided aortic arch, anomalous origin of the right pulmonary artery from the aorta, supravalvular pulmonary stenosis, secundum atrial septal defect, and membranous ventricular septal defect. Seizures developed in the first 20 hours and were controlled by phenobarbital. The infant died at 19 days of age of congestive heart failure. Autopsy showed mild focal microgyria but no obvious subcortical ectopic neurons. Inferior olives were in the form of a broad band, with no obvious concentration of neurons around the periphery. A similarly affected elder sib had died at 15 days of age. Both patients 1 and 2 lacked peroxisomes. Lab values were all abnormal and fell in ranges observed for patients with peroxisome biogenesis disorders.

Muntau et al. (2000) reported 2 unrelated patients with Zellweger syndrome of complementation group G. The patients were male infants from unrelated consanguineous Dutch and Italian families. One showed marked muscular hypotonia at birth. Dysmorphic features included hypertelorism, prominent epicanthic folds, and a high, broad forehead with round face. Seizures developed on day 1 but were controlled with treatment. His condition deteriorated rapidly, with death at age 4 months. The other patient was cyanotic and markedly hypotonic at birth with absent deep tendon reflexes. He had a prominent midface and an antimongoloid slant of the palpebral fissures, ocular hypertelorism, small low-set ears, a prominent nose, and a high-arched palate. The patient died at age 19 days. A brother had been similarly affected and died at age 15 days.


Molecular Genetics

In 2 unrelated patients with Zellweger syndrome of complementation group G, Muntau et al. (2000) identified 2 different homozygous mutations in the PEX3 gene (603164.0001, 603164.0002).


REFERENCES

  1. Muntau, A. C., Mayerhofer, P. U., Paton, B. C., Kammerer, S., Roscher, A. A. Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G. Am. J. Hum. Genet. 67: 967-975, 2000. [PubMed: 10958759] [Full Text: https://doi.org/10.1086/303071]

  2. Poulos, A., Christodoulou, J., Chow, C. W., Goldblatt, J., Paton, B. C., Orii, T., Suzuki, Y., Shimozawa, N. Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J. Pediat. 127: 596-599, 1995. [PubMed: 7562283] [Full Text: https://doi.org/10.1016/s0022-3476(95)70121-4]

  3. Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., Moser, H. W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763: 1733-1748, 2006. [PubMed: 17055079] [Full Text: https://doi.org/10.1016/j.bbamcr.2006.09.010]


Contributors:
Anne M. Stumpf - updated : 02/14/2017

Creation Date:
Anne M. Stumpf : 10/17/2012

Edit History:
carol : 03/02/2017
alopez : 02/14/2017
alopez : 10/25/2012
carol : 10/25/2012
alopez : 10/24/2012